Neutropenia risk factors: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{ Neutropenia }} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{Reflist|..." |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ Neutropenia }} | {{ Neutropenia }} | ||
{{CMG}} {{AE}} {{DG}} | |||
==Overview== | |||
At-risk populations include those undergoing [[cytotoxic]] [[chemotherapy]] or other myelosuppressive medications, however a benign form of mild [[neutropenia]] is commonly identified in certain ethnicities (blacks, Yemenites, West Indians, Arab Jordanians). This latter group rarely develops complications from their neutropenia. | |||
==Risk Factors== | |||
* [[Medications]]<ref name="PMID17142169">{{cite journal |author=Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. |title=Idiosyncratic drug-induced agranulocytosis: Update of an old disorder. |journal=Eur J Intern Med. |volume=17|issue=8 |pages=529-35 |year=2006|pmid 17142169|doi=|url=https://www.ncbi.nlm.nih.gov/pubmed/17142169}}</ref> | |||
* [[List of chemotherapeutic agents#Cytotoxic Chemotherapy|Cytotoxic chemotherapy]] | |||
* Hematologic malignancies | |||
* [[Autoimmune disorders]] | |||
* Infections | |||
* [[Hemodialysis]] | |||
* [[Radiation therapy]] | |||
* [[avitaminosis|Vitamin deficiencies e.g. folate, Vitamin B12]] | |||
* Black, Yemenite, West Indian, or Arab Jordanian ethnicity | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 00:18, 17 November 2016
|
Neutropenia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neutropenia risk factors On the Web |
|
American Roentgen Ray Society Images of Neutropenia risk factors |
|
Risk calculators and risk factors for Neutropenia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Daniel A. Gerber, M.D. [2]
Overview
At-risk populations include those undergoing cytotoxic chemotherapy or other myelosuppressive medications, however a benign form of mild neutropenia is commonly identified in certain ethnicities (blacks, Yemenites, West Indians, Arab Jordanians). This latter group rarely develops complications from their neutropenia.
Risk Factors
- Medications[1]
- Cytotoxic chemotherapy
- Hematologic malignancies
- Autoimmune disorders
- Infections
- Hemodialysis
- Radiation therapy
- Vitamin deficiencies e.g. folate, Vitamin B12
- Black, Yemenite, West Indian, or Arab Jordanian ethnicity
References
- ↑ Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. (2006). "Idiosyncratic drug-induced agranulocytosis: Update of an old disorder". Eur J Intern Med. 17 (8): 529–35. Text "pmid 17142169" ignored (help)